SHINE is dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements.
SHINE was founded in 2010 by Greg Piefer and is a development-stage company working toward becoming a manufacturer of radioisotopes for nuclear medicine.
The SHINE production facility will use a patented, proprietary manufacturing process that offers major advantages over existing and proposed production technologies, as it does not require a nuclear reactor, uses less electricity, generates less waste and is compatible with the existing global supply chain for molybdenum-99.
SHINE will build its first manufacturing facility in Janesville, Wisconsin. This facility will be capable of producing up to one-third of global demand and will primarily serve the U.S. and European markets.
SHINE is in the process of evaluating potential sites for a second facility, primarily to serve Asia and the Middle East.